Novel Therapies for Resistant FSGS (FONTII): Phase II Clinical Trial

Clinical trial NCT00814255 · COMPLETED

Trial details

NCT number: NCT00814255
Sponsor: NYU Langone Health
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Focal Segmental Glomerulosclerosis

Start date: 2008-12-01
Primary completion: 2013-06-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.